Scientists working on cat vaccine to relieve allergic reactions in humans


INDIANAPOLIS (WTHR) — If you suffer from a cat allergy, you're like millions of others. But help may be on the way.

Scientists in Switzerland are working on a vaccine called "HypoCat." The vaccination would minimize cats secretions of the Fel d 1 allergen, a protein of which approximately 10 percent of the population in the Western hemisphere is allergic.

According to the American College of Allergy, Asthma and Immunology, cat allergies are twice as common as dog allergies.

Four separate studies were conducted on a total of 54 cats to test the vaccination and it shows promising results.

“We are very pleased to publish this data which shows our HypoCat™ vaccine is able to produce high levels of antibodies in cats and that these antibodies can bind and neutralize the Fel d 1 allergen produced by the animals," according to HypoPet's website.

The CEO of HypoPet AG, Dr. Gary Jennings, said he's hoping to bring the "much-needed product" to the United States and Europe.